Clinical Trial Update: A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the effects of itraconazole on MK-1708 in healthy participants, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Itraconazole (Itraconazole)
• MK-1708

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED